A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study.

Rafael Ríos-Tamayo,Juan Alfons Soler,Ricarda García-Sánchez,Ernesto Pérez Persona,Mario Arnao,Antoni García-Guiñón,Abel Domingo,Miriam González-Pardo,Javier de la Rubia,María Victoria Mateos

Hematology (Amsterdam, Netherlands)（2023）

引用 0|浏览3

暂无评分

摘要

The incorporation of mAb in RW practice for the treatment of RRMM has shown good quality and speed of response with a similar safety profile shown in randomized clinical trials.

查看译文

关键词

Relapsed-refractory multiple myeloma,daratumumab,monoclonal antibodies,real-world,standard of care

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要